연구업적

연구

연구
연구업적

최근 5년 연구업적 현황

연도		2024년	2023년	2022년	2021년	2020년
SCI 논문 발표편수	책임	179편	173편	163편	184편	135편
SCI 논문 발표편수	공동	147편	120편	115편	136편	168편
합계		326편	293편	278편	320편	303편

727. Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer.

Lee KW, Kim JH, Yun T, Song EK, Na II, Shin H, Oh SY, Choi IS, Oh do Y, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK.

J Korean Med Sci. 2007 Sep;22 Suppl:S115-21 Link

726. Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer.

Han SW, Jeon YK, Lee KH, Keam B, Hwang PG, Oh DY, Lee SH, Kim DW, Im SA, Chung DH, Heo DS, Bang YJ, Kim TY.

Pharmacogenet Genomics. 2007 May;17(5):313-9 Link

725. Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy.

Jung Y, Park J, Kim TY, Park JH, Jong HS, Im SA, Robertson KD, Bang YJ, Kim TY.

J Mol Med. 2007 Oct;85(10):1137-48. Link

724. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.

Lee KH, Min HS, Han SW, Oh DY, Lee SH, Kim DW, Im SA, Chung DH, Kim YT, Kim TY, Heo DS, Bang YJ, Sung SW, Kim JH.

Lung Cancer. 2007 Nov 22 Link

723. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

BMC Cancer. 2007 Apr 12;7:63. Link

722. Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer.

Keam B, Im SA, Kim HJ, Oh DY, Kim JH, Lee SH, Chie EK, Han W, Kim DW, Moon WK, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

BMC Cancer. 2007 Nov 1;7(1):203 Link

721. A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer.

Kim YJ, Im SA, Kim HG, Oh SY, Lee KW, Choi IS, Oh DY, Lee SH, Kim JH, Kim DW, Kim TY, Kim SW, Heo DS, Yoon YB, Bang YJ.

Ann Oncol. 2008 Jan;19(1):99-103. Epub 2007 Sep 9 Link

720. Development of 3-D nanofibrous fibroin scaffold with high porosity by electrospinning: implications for bone regeneration.

Ki CS, Park SY, Kim HJ, Jung HM, Woo KM, Lee JW, Park YH.

Biotechnology Letters. Epub 2007 Nov. 1 Link

719. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.

H Jung, K P Lee, S J Park, J H Park, Y-S Jang, S-Y Choi, J-G J, K Jo, D Y Park, J H Yoon, J-H Park, D-S Lim, Y-K Park, G-R Hong, C Choi, J W Lee, H J Hong, S Kim, and Y W Park.

Oncogene. 2007 Oct 29 [Epub ahead of print] Link

718. DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma.

Kim T-Y, Lee J.W, Kim H-P, Jong H-S, Kim T-Y, Jung M., and Bang Y-J.

Biochem. Biophys. Res. Commun. 2007 Mar 30;355(1):72-77 Link